Sign in

CIK 0001650648 · Non-accelerated filer<br>Smaller reporting company

4D Molecular Therapeutics, Inc.

Sign in to watch
Ticker
FDMT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
473506994
Phone
5105052680
Business address
5858 HORTON STREET #455, EMERYVILLE, CA, 94608
Former names
4D Molecular Therapeutics Inc., 4D Molecular Therapeutics Inc
  1. S-8 Other Securities Offered to Employees in Benefit Plans
  2. 10-K Report Annual Report
  3. 8-K Event Results of operations
  4. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  5. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  6. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  7. SCHEDULE 13G Stake Statement of Beneficial Ownership
  8. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  9. 8-K Event Unregistered share sale
  10. 4 Derivatives Options or other derivatives
  11. 3 Insider Initial Statement of Ownership
  12. 8-K Event Results of operations · Executive or director change
  13. 4 Open-market sale VP, Finance and Controller sold 389 shares at $8.68 ($3,377)
  14. 3 Insider Initial Statement of Ownership
  15. 4 Planned sale Chief Legal Officer sold 1,635 shares at $10.90 ($17,822)
  16. 4 Option exercise Director acquired 9,333 shares (option exercise)
  17. 144 Insider Sale of Securities
  18. 4 Derivatives Options or other derivatives
  19. 3 Insider Initial Statement of Ownership
  20. 8-K Event Other events

Page 4 of 22 · 440 filings